SPI Pharma

High‑performance excipient platforms for faster development, better mouthfeel, robust tablets and reliable effervescents — from lab to commercial scale.
SPI Pharma delivers patient‑centric excipient platforms that solve real formulation problems - from flash and classic ODTs to effervescents, soft‑gel optimization and high‑load DC tablets. With proven technologies like Pharmaburst® 500, UltraBurst™, Mannogem® XL, Advantol® 300, Effer‑Soda® and Pharmasperse® 416, teams can improve disintegration, mouthfeel, flow, hardness, friability and stability while simplifying scale‑up across nutraceutical, food* (where applicable) and pharmaceutical products.

Benefits

Applications

  • Shorter development timelines using proven formulation systems.
  • Improved mixability, flow, mouthfeel and processing efficiency.
  • Enhanced solubility, dispersibility and stability across delivery formats.
  • Support for clean‑label, premium and science‑led product positioning.
  • Reliable performance across soft gels, powders, bars, beverages and gummies.
  • Powders (RTM, sachets, sticks)
  • Tablets & ODTs
  • Gummies & soft chews
  • Soft gels & liquid fills
  • Functional foods & fortified beverages
  • Nutritional bars & dry‑mix systems

How Biotexia ANZ Can Help

We work alongside your team to identify the right enabling system for your formulation needs—whether you’re improving flow in a powder blend, enhancing solubility in a soft gel, designing a cleaner label, or solving texture and stability challenges.
Our partnerships with SPI Pharma give you access to global innovation backed by local technical and regulatory support, ensuring your product performs from pilot to full‑scale manufacturing.